Proposal for Cartilage Defect Diagnostic Support Technology with FUJIFILM
First written in FY2018. 2 of 5 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024DroppedAnnual reportThe FY2024 main text does not identify proposals or sales initiatives for cartilage-defect diagnostic support using Fujifilm's SYNAPSE VINCENT and other products as a separate theme.
- FY2020AdvancedAnnual report
「We had been pursuing synergies with knee diagnosis using Fujifilm's 3D image analysis system SYNAPSE VINCENT, but began selling this and other Fujifilm medical devices in the current fiscal year to accelerate these efforts and bring forward their contribution to sales.」
Collaboration with Fujifilm on cartilage-defect diagnostic support has been given concrete form through the start of sales of SYNAPSE VINCENT and other medical devices. - FY2020-Q2RestatedAnnual report
「To demonstrate the benefits of this change, we are compiling comprehensive evidence, including clinical data, while also pursuing synergies with knee diagnosis using Fujifilm's 3D image analysis system “SYNAPSE VINCENT.” We will increase repeat use, develop new facilities and expand orders.」
The company continues to pursue a policy of supporting knee diagnosis through collaboration with Fujifilm and use of its systems, thereby promoting JACC and expanding orders. - FY2019RestatedAnnual report
「Through collaboration with FUJIFILM, we aim to establish technology supporting the diagnosis of cartilage defects and promote further adoption of the product by enabling cartilage defects to be diagnosed accurately and easily.」
The company continues to pursue the establishment of cartilage-defect diagnostic support technology through collaboration with Fujifilm and its use to promote JACC (autologous cultured cartilage product). - FY2018First statedAnnual report
「We will therefore also work with FUJIFILM to propose technology supporting the diagnosis of cartilage defects.」
To make it easier and more accurate to identify cartilage defects, which are an indication requirement for JACC, and thereby promote wider adoption, the Company presented collaboration with FUJIFILM on diagnostic support technology as a new initiative.